Stock DSGN DESIGN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Design Therapeutics, Inc.

Equities

DSGN

US25056L1035

Real-time Estimate Cboe BZX
Other stock markets
 10:53:44 2024-06-06 EDT 		5-day change 1st Jan Change
4.165 USD +0.12% Intraday chart for Design Therapeutics, Inc. +5.84% +57.36%
05-08 Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-07 Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
DESIGN THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+0.24%+5.84%+57.36%-26.19% - 235M
Neutral
Bullish
Neutral
  1. Stock Market
  2. Equities
  3. DSGN Stock
  4. Charts Design Therapeutics, Inc.
  5. Relative Strength Chart